WhiteHawk Therapeutics, Inc. is a biotechnology company focused on the research and development of therapeutics, particularly in oncology. The company specializes in antibody-drug conjugates (ADCs) and other targeted cancer therapies, guiding products from development through commercialization. WhiteHawk operates in the life sciences sector, serving healthcare providers and patients in various markets. Its leadership team comprises experts with extensive experience in drug development and commercialization within the biotechnology and pharmaceutical industries.
- Website
- www.whitehawktx.com
- Issuer profile
- All listings